- Home
- BLTE vs BGM Comparison
BLTE vs BGM Comparison
Compare BLTE & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- BGM
- Stock Information
- Founded
- BLTE 2018
- BGM 2019
- Country
- BLTE United States
- BGM China
- Employees
- BLTE N/A
- BGM N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- BLTE Health Care
- BGM
- Exchange
- BLTE Nasdaq
- BGM NYSE
- Market Cap
- BLTE 2.1B
- BGM 2.5B
- IPO Year
- BLTE 2022
- BGM 2021
- Fundamental
- Price
- BLTE $60.48
- BGM $13.30
- Analyst Decision
- BLTE Strong Buy
- BGM
- Analyst Count
- BLTE 4
- BGM 0
- Target Price
- BLTE $96.67
- BGM N/A
- AVG Volume (30 Days)
- BLTE 32.1K
- BGM 86.3K
- Earning Date
- BLTE 08-08-2025
- BGM 08-13-2025
- Dividend Yield
- BLTE N/A
- BGM N/A
- EPS Growth
- BLTE N/A
- BGM N/A
- EPS
- BLTE N/A
- BGM N/A
- Revenue
- BLTE N/A
- BGM $25,097,951.00
- Revenue This Year
- BLTE N/A
- BGM N/A
- Revenue Next Year
- BLTE N/A
- BGM N/A
- P/E Ratio
- BLTE N/A
- BGM N/A
- Revenue Growth
- BLTE N/A
- BGM N/A
- 52 Week Low
- BLTE $43.70
- BGM $5.26
- 52 Week High
- BLTE $86.53
- BGM $17.17
- Technical
- Relative Strength Index (RSI)
- BLTE 46.26
- BGM 50.76
- Support Level
- BLTE $58.55
- BGM $12.55
- Resistance Level
- BLTE $62.49
- BGM $17.17
- Average True Range (ATR)
- BLTE 1.81
- BGM 1.42
- MACD
- BLTE -0.40
- BGM -0.19
- Stochastic Oscillator
- BLTE 26.19
- BGM 32.01
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.